Chain Pharmacy

As America's diverse population continues to grow, disparities in healthcare delivery have become more prevalent. Studies show that when it comes to healthcare benchmarks, many racial and ethnically diverse populations are at a disadvantage

Tats and studs and rap and hip-hop can turn off patients and send them on a search for the real pharmacist. You're a medical professional. You need to look and sound the part.

A letter about Walgreens' POWER program gets David Stanley asking questions.

A roundup of information on CHA2DS2-VASc score versus CHADS2 as a thromboembolism determinant; the incidence of pulmonary embolism in knee arthroscopy patients; the increase of venous thromboembolism with antipsychotic drug use.

DEA's "Office of Diversion Control" prevents, detects, and investigates the diversion of controlled substances from legitimate sources while ensuring an adequate and uninterrupted supply for legitimate medical needs. To accomplish this mission, the DEA sets forth regulations designed to prevent any such diversion.

Both the Food and Drug Administration and officials from a number of generic drug companies indicate they are in active talks on creating user fees to be paid by that industry to give the agency more resources to speed generics to the market, carry out inspections and other functions.

While Purdue Pharma, the manufacturer of OxyContin, has offered the State of Florida $1 million for a pill mill database, the anticipated cost of sustaining the program may deter Florida Governor Rick Scott and other legislators from accepting the grant.

New data suggest that certain prescription drug products are associated with aggression and violence toward others.

For patients seeking new ways to keep their breath fresher and their pearly whites whiter, today's manufacturers continue to develop and rebrand products to better address both the health and beauty aspects of oral care.

The U.S. Senate last month voted to repeal a 1099 tax-filing requirement that would have been time-consuming for retail pharmacists.

Drug-seekers will go to sometimes ludicrous lengths to get what they want. For the addict's equivalent of "The dog ate my homework," read on.

The California Pharmacists Association has launched what may be the nation's first employee pharmacist ombudsman program sponsored by a state association.

Patents on many small-molecule drugs, which make up some of the most popular prescription medications in the world, are set to expire during the next several years, an occurrence that is expected to cause an unprecedented shift of billions of dollars in sales to generics in the United States and other markets.

Very few state laws require a pharmacy to use a drug container that meets minimum quality-control standards. Legal metrics are needed to guard against possible patient harm resulting from an adulterated drug product caused by a "bad" container.

Technology giant Intel recently opened a health and wellness center for employees at its Jones Farm Campus in Hillsboro, Ore., that will replace many tedious trips to the doctor's office with services provided on site.

The selection of an incorrect prescriber during the prescription order entry process may have consequences long after the prescription is filled.

The skepticism of modern medicine toward the placebo effect has kept a study proving its validity hidden in the shadows of medical research instead of giving it the attention it deserves.

New guidelines in a 2010 report issued by the Centers for Disease Control and Prevention for the treatment of sexually transmitted diseases contain major updates to its 2006 report that could prove significant for the nation's pharmacies.

Recent data suggest that thrombopoietin receptor agonists are safe and effective for the treatment of chronic immune thrombocytopenic purpura, or ITP, over at least 6 years.

The American Society of Health-System Pharmacists and 3 other healthcare industry groups are working to transform regulations to ease U.S. drug shortages.

A survey of new Rx, new generic, and new OTC products

Launched in January, The Prevention Plan is an online health-screening and primary prevention program similar to wellness plans already being marketed to employer groups. It costs $99.

FDA is limiting the amount of acetaminophen in prescription drug products, primarily combinations of acetaminophen and opioids.

Consumer out-of-pocket cost is the leading reason for members' failure to pick up filled prescriptions (drug abandonment), according to the healthcare data company Wolters Kluwer Pharma Solutions. The firm reports that by the second quarter of 2010, the drug-abandonment rate had risen 55% in 4 years.

A new prescription drug label format is in the works. Draft standards from the U.S. Pharmacopeial Convention could bring dramatic changes to Rx labels in 2012.